Purchases and Sales Made in Q3 2020 in Salarius Pharmaceuticals, Inc. (SLRX)
This table provides information about the institutional ownership of Salarius Pharmaceuticals, Inc. (SLRX) during Q3 2020. The information is specifically focused on institutions that hold shares of Salarius Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2020
Q3 2020
|
Kepos Capital LP
New York, NY |
BUY
|
- |
125KNew |
$96.3K - $190K
|
125K
$231K
|
|
|
Nov 16, 2020
Q3 2020
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
52.6KNew |
$40.5K - $80K
|
52.6K
$97.3K
|
|
|
Nov 16, 2020
Q3 2020
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
27.2KNew |
$20.9K - $41.3K
|
27.2K
$50.3K
|
|
|
Nov 16, 2020
Q3 2020
|
Squarepoint Ops LLC
New York, NY |
BUY
|
- |
11.7KNew |
$9.05K - $17.9K
|
11.7K
$21.7K
|
|
|
Nov 16, 2020
Q3 2020
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
11.6KNew |
$8.95K - $17.7K
|
11.6K
$21.5K
|
|
|
Nov 16, 2020
Q3 2020
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
9.34K+ 73.05% |
$7.19K - $14.2K
|
22.1K
$40.9K
|
|
|
Nov 12, 2020
Q3 2020
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
BUY
|
- |
1.75K+ 184.39% |
$1.35K - $2.66K
|
2.7K
$4.99K
|
|
|
Nov 05, 2020
Q3 2020
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
20+ 25.64% |
$15.4 - $30.4
|
98
$181
|
|
|
Nov 13, 2020
Q3 2020
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 12, 2020
Q3 2020
|
Bank Of New York Mellon Corp
New York, NY |
SELL
|
- |
-180- 0.4% |
$139 - $274
|
45K
$83.3K
|
|
|
Nov 12, 2020
Q3 2020
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-1.63KClosed |
$1.26K - $2.48K
|
0
$0
|
|
|
Nov 13, 2020
Q3 2020
|
Rmr Wealth Builders
|
SELL
|
- |
-3KClosed |
$2.31K - $4.56K
|
0
$0
|